Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 976 AL 990

Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease

Villegas-Llerena C, Phillips A, Garcia-Reitboeck P, Hardy J, Pocock JM.

Curr Opin Neurobiol. 2016 Feb;36:74-81. doi: 10.1016/j.conb.2015.10.004. Epub 2015 Oct 24.

Microglial toll-like receptors and Alzheimer's disease

Su F, Bai F, Zhou H, Zhang Z.

Brain Behav Immun. 2016 Feb;52:187-198. doi: 10.1016/j.bbi.2015.10.010. Epub 2015 Oct 23.

The pathogenesis of soluble PrP fragments containing Aβ binding sites

Li B.

Virus Res. 2016 Jan 4;211:194-8. doi: 10.1016/j.virusres.2015.10.023. Epub 2015 Oct 31.

Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease

Venigalla M, Sonego S, Gyengesi E, Sharman MJ, Münch G.

Neurochem Int. 2016 May;95:63-74. doi: 10.1016/j.neuint.2015.10.011. Epub 2015 Oct 31.

Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer's Disease and Other Tauopathies

Schroeder SK, Joly-Amado A, Gordon MN, Morgan D.

J Neuroimmune Pharmacol. 2016 Mar;11(1):9-25. doi: 10.1007/s11481-015-9637-6. Epub 2015 Nov 4.

Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology

Ishii M, Iadecola C.

Biochim Biophys Acta. 2016 May;1862(5):966-74. doi: 10.1016/j.bbadis.2015.10.029. Epub 2015 Nov 9.

Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease

Lian H, Zheng H.

J Neurochem. 2016 Feb;136(3):475-91. doi: 10.1111/jnc.13424. Epub 2015 Nov 30.

Defining the Genetic Architecture of Alzheimer's Disease: Where Next

Sims R, Williams J.

Neurodegener Dis. 2016;16(1-2):6-11. doi: 10.1159/000440841. Epub 2015 Nov 10.

Tau Immunotherapy

Sigurdsson EM.

Neurodegener Dis. 2016;16(1-2):34-8. doi: 10.1159/000440842. Epub 2015 Nov 10.

Tau as the Converging Protein between Chronic Stress and Alzheimer's Disease Synaptic Pathology

Sotiropoulos I, Sousa N.

Neurodegener Dis. 2016;16(1-2):22-5. doi: 10.1159/000440844. Epub 2015 Nov 10.

Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition

Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative*.

Eur Radiol. 2016 Aug;26(8):2597-610. doi: 10.1007/s00330-015-4101-9. Epub 2015 Nov 11.

Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease

Maqbool M, Mobashir M, Hoda N.

Eur J Med Chem. 2016 Jan 1;107:63-81. doi: 10.1016/j.ejmech.2015.10.018. Epub 2015 Oct 21.

Developing therapeutic vaccines against Alzheimer's disease

Wisniewski T, Drummond E.

Expert Rev Vaccines. 2016;15(3):401-15. doi: 10.1586/14760584.2016.1121815. Epub 2015 Dec 11.

Understanding Pre-Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint

Cheng SB, Nakashima A, Sharma S.

Am J Reprod Immunol. 2016 Mar;75(3):372-81. doi: 10.1111/aji.12446. Epub 2015 Nov 20.

Chronic exposure to aluminum and risk of Alzheimer's disease: A meta-analysis

Wang Z, Wei X, Yang J, Suo J, Chen J, Liu X, Zhao X.

Neurosci Lett. 2016 Jan 1;610:200-6. doi: 10.1016/j.neulet.2015.11.014. Epub 2015 Nov 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias